Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2007-10-11

Clinical Trial Update: Mycophenolate Sodium Treatment in Patients With Primary Sjogren's Syndrome [Phase 1]

View source ↗

Summary

Phase 1 clinical trial investigating mycophenolate sodium in patients with Primary Sjogren's Syndrome; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mycophenolate sodium (mycophenolate sodium)

Snippet

Sponsor: University Hospital Muenster | Conditions: Primary Sjogren's Syndrome | Phase 1 | Status: COMPLETED